Early Life Social, Environmental, and Nutritional Determinants of Disease (ELSEND)
疾病的早期社会、环境和营养决定因素 (ELSEND)
基本信息
- 批准号:10494264
- 负责人:
- 金额:$ 88.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAffectAgeAir PollutantsAir PollutionAttenuatedBehavioralBiologicalBirthBreast FeedingCaliforniaChildChildhoodChronicChronic DiseaseClinicalCommunitiesCountyDataDietDietary InterventionDiseaseDisease MarkerDyslipidemiasEnvironmentEnvironmental ExposureEnvironmental Risk FactorEnzymesExposure toFamilyFatty acid glycerol estersFibrosisFood AccessFundingFutureGlycosylated hemoglobin AGrowthHealthHeightIndividualInfantInterventionJuiceLatinoLatino PopulationLifeLipidsLiverLos AngelesMagnetic Resonance ImagingMaternal HealthMeasuresMothersNeighborhoodsNon-Insulin-Dependent Diabetes MellitusNutritionalObesityOutcomeOutcome MeasureParentsPregnancyProgressive DiseasePublic HealthRiskRisk FactorsToxic Environmental SubstancesToxinTreatment EfficacyUnited States National Institutes of HealthUpdateWeightWorkbaseblood glucose regulationbuilt environmentcohortcomparative efficacydisorder riskdisparity eliminationearly life exposureearly-life nutritionelastographyfeedingfollow-upfood environmentglucose monitorglycemic controlhealth disparityimprovedindexingintervention effectmother nutritionnon-alcoholic fatty liver diseasenutritionobesity in childrenrandomized trialsocialsocial health determinantssocial structuresocioenvironmental factorsugarsweetened beverage
项目摘要
Latinos are disproportionately affected by multiple chronic diseases, including obesity, type 2 diabetes (T2D),
non-alcoholic fatty liver disease (NAFLD), and dyslipidemia, and this begins in early life. Understanding and
eliminating these disparities is a national priority given the clinical and public health burden associated with these
co-existing chronic diseases. Our work over the last 20 years in Latino infants and children has identified 3
recurring risk factors for these chronic diseases that emerge early in life: 1) formula feeding rather than
breastfeeding, as well as formula type (i.e., formula with added sugar); 2) early introduction of sugar sweetened
beverages and juices (SSB/J), and 3) environmental exposure to air pollution. Despite this, prior work in young
Latino children is limited to assessment of obesity outcomes based on height and weight and lacks robust
measures of adiposity and other sub-clinical markers of future chronic disease risk. In addition, no prior study
has holistically examined these risk factors in the context of broader environmental factors and social
determinants of health (SDOH) that may exacerbate their impact on health outcomes. We propose a
comprehensive study in Latino children to examine the contributions of early-life nutrition, exposure to
environmental toxins, and SDOH on subclinical markers of chronic disease risk at 5y of age. We will leverage 2
NIH-funded birth cohorts led by Dr. Goran (R01DK110793; R01DK109161), which have already thoroughly
characterized early-life exposures in Latino infants from Los Angeles County, with repeated assessments in the
first 2y of life. We will combine these cohorts and collect new outcome measures at 5y of age in the proposed
Early Life Social, Environmental, and Nutritional Determinants of Disease (ELSEND) study. In ELSEND, we will
collect follow-up measures from 190 children at 5y of age using robust subclinical markers of progressive
disease, including non-invasive assessments of fat distribution by magnetic resonance imaging (MRI), liver fat
and fibrosis by MRI and elastography, and blood glucose regulation by continuous glucose monitoring (CGM)
over 7 days. We will update nutritional information and current and cumulative environmental exposures (air
pollution, CalEnviroScreen Index), and will collect new data on broader SDOH, including geospatial assessments
of social and structural factors such as the neighborhood and built environment. This project will address the
following aims: 1) Assess whether early nutrition and/or exposure to environmental toxins is associated with child
growth and/or risk for chronic disease at age 5y; 2) Assess if the food environment and broader SDOH is
associated with subclinical markers of disease and if they exacerbate the adverse effects of poor nutrition and/or
environmental toxins. In addition, by combining data from children across all 3 Center projects, we will also
examine the associations between social and environmental exposures and childhood diet with risk factors for
chronic disease in 530 children across Southern California, and explore whether the efficacy of 3 different family-
based interventions is impacted by individual and/or community level environmental factors.
拉丁美洲人尤其容易受到多种慢性疾病的影响,包括肥胖、2 型糖尿病 (T2D)、
非酒精性脂肪肝病 (NAFLD) 和血脂异常,这从生命早期就开始了。理解和
鉴于与这些相关的临床和公共卫生负担,消除这些差异是国家优先事项
并存的慢性疾病。过去 20 年我们在拉丁裔婴儿和儿童方面的工作发现了 3
这些生命早期出现的慢性疾病的反复危险因素:1)配方奶喂养而不是
母乳喂养以及配方奶类型(即添加糖的配方奶); 2)早期引入糖加甜
饮料和果汁 (SSB/J),以及 3) 环境暴露于空气污染。尽管如此,之前在年轻人中的工作
拉丁裔儿童仅限于根据身高和体重评估肥胖结果,缺乏可靠的依据
肥胖和未来慢性病风险的其他亚临床标志物的测量。另外,之前没有研究过
在更广泛的环境因素和社会因素的背景下全面审查了这些风险因素
健康决定因素(SDOH)可能会加剧其对健康结果的影响。我们提出一个
对拉丁裔儿童进行的综合研究,旨在考察生命早期营养、接触
环境毒素和 SDOH 对 5 岁慢性病风险的亚临床标志物的影响。我们将利用2
由 Goran 博士(R01DK110793;R01DK109161)领导的 NIH 资助的出生队列,已经彻底
描述了来自洛杉矶县的拉丁裔婴儿的早期暴露情况,并在
生命的最初 2 年。我们将结合这些队列,并在拟议的 5 岁年龄收集新的结果指标
疾病的早期社会、环境和营养决定因素 (ELSEND) 研究。在ELSEND,我们将
使用稳健的亚临床进展标记物收集 190 名 5 岁儿童的后续措施
疾病,包括通过磁共振成像(MRI)、肝脏脂肪对脂肪分布进行非侵入性评估
通过 MRI 和弹性成像进行纤维化,通过连续血糖监测 (CGM) 进行血糖调节
超过7天。我们将更新营养信息以及当前和累积的环境暴露(空气
污染、CalEnviroScreen 指数),并将收集更广泛的 SDOH 的新数据,包括地理空间评估
社会和结构因素,例如社区和建筑环境。该项目将解决
以下目标: 1) 评估早期营养和/或接触环境毒素是否与儿童有关
5 岁时的生长发育和/或慢性病风险; 2) 评估食品环境和更广泛的 SDOH 是否
与疾病的亚临床标志物相关,以及它们是否加剧营养不良和/或
环境毒素。此外,通过结合所有 3 个中心项目的儿童数据,我们还将
检查社会和环境暴露与儿童饮食与危险因素之间的关联
对南加州 530 名儿童的慢性病进行了研究,并探讨 3 个不同家庭的疗效是否
基于的干预措施受到个人和/或社区层面环境因素的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Isaac Goran其他文献
Michael Isaac Goran的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Isaac Goran', 18)}}的其他基金
Food Prescriptions to Promote Affordable Diets that Meet RDAs Among Multi-Generational Latino Households
在多代拉丁裔家庭中推广符合 RDA 的负担得起的饮食的食品处方
- 批准号:
10886186 - 财政年份:2023
- 资助金额:
$ 88.82万 - 项目类别:
Understanding and Targeting the Pathophysiology of Youth-onset Type2 Diabetes
了解并针对青年发病 2 型糖尿病的病理生理学
- 批准号:
10583413 - 财政年份:2023
- 资助金额:
$ 88.82万 - 项目类别:
Southern California Center for Chronic Health Disparities in Latino Children and Families
南加州拉丁裔儿童和家庭慢性健康差异中心
- 批准号:
10825371 - 财政年份:2021
- 资助金额:
$ 88.82万 - 项目类别:
Early Life Social, Environmental, and Nutritional Determinants of Disease (ELSEND)
疾病的早期社会、环境和营养决定因素 (ELSEND)
- 批准号:
10437271 - 财政年份:2021
- 资助金额:
$ 88.82万 - 项目类别:
Southern California Center for Chronic Health Disparities in Latino Children and Families
南加州拉丁裔儿童和家庭慢性健康差异中心
- 批准号:
10886169 - 财政年份:2021
- 资助金额:
$ 88.82万 - 项目类别:
Southern California Center for Chronic Health Disparities in Latino Children and Families.
南加州拉丁裔儿童和家庭慢性健康差异中心。
- 批准号:
10656504 - 财政年份:2021
- 资助金额:
$ 88.82万 - 项目类别:
Southern California Center for Chronic Health Disparities in Latino Children and Families.
南加州拉丁裔儿童和家庭慢性健康差异中心。
- 批准号:
10674434 - 财政年份:2021
- 资助金额:
$ 88.82万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 88.82万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 88.82万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 88.82万 - 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:
10735117 - 财政年份:2023
- 资助金额:
$ 88.82万 - 项目类别: